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A b s t r a c t
Introduction: Low frequency electromagnetic fields (LF-EMF) and simulated 
microgravity (SMG) have been observed to affect chondrogenesis. A  con-
trolled bioreactor system was developed to apply LF-EMF and SMG singly or 
combined during chondrogenic differentiation of human mesenchymal stem 
cells (hMSCs) in 3D culture. 
Material and methods: An external motor gear SMG bioreactor was com-
bined with magnetic Helmholtz coils for EMF (5 mT; 15 Hz). Pellets of hMSCs 
(±TGF-β3) were cultured (P5) under SMG, LF-EMF, LF-EMF/SMG and control 
(1 g) conditions for 3 weeks. Sections were stained with safranin-O and col-
lagen type II. Gene expression was evaluated by microarray and real-time 
polymerase chain reaction analysis. 
Results: Simulated microgravity application significantly changed gene ex-
pression; specifically, COLXA1 but also COL2A1, which represents the chon-
drogenic potential, were reduced (p < 0.05). Low frequency electromagnetic 
fields application showed no gene expression changes on a microarray basis. 
LF-EMF/SMG application obtained significant different expression values 
from cultures obtained under SMG conditions with a re-increase of COL2A1, 
therefore rescuing the chondrogenic potential, which had been lowered by 
SMG.
Conclusions: Simulated microgravity lowered hypertrophy but also the 
chondrogenic potential of hMSCs. Combined LF-EMF/SMG provided a rescue 
effect of the chondrogenic potential of hMSCs although no LF-EMF effect 
was observed under optimal conditions. The study provides new insights 
into how LF-EMF and SMG affect chondrogenesis of hMSCs and how they 
generate interdependent effects.
Key words: bioreactor, electromagnetic fields, simulated microgravity, 
chondrogenesis.
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Introduction
Untreated cartilage defects in adults lead to 
osteoarthritis as there is no spontaneous repair 
mechanism which is able to completely restore 
physiological tissue structure and function [1, 2]. 
Procedures such as matrix-associated autologous 
chondrocyte transplantation (MACT) are used to 
facilitate the regenerative capacity and improve 
clinical outcome. As the use of chondrocytes is as-
sociated with donor site morbidity and dedifferen-
tiation, human mesenchymal stem cells (hMSCs) 
might provide an opportunity to obtain a  suf- 
ficient amount of cartilaginous cells. Advanced cell 
therapies for articular cartilage regeneration are 
developed using various bioreactor systems [3]. 
The main challenge in chondrogenic differentia-
tion of hMSCs is to prevent terminal ossification 
represented by hypertrophy and at the same time 
maintain the chondrogenic potential of cells [4]. 
Adjuvant therapies such as electromagnetic 
fields (EMF) and simulated microgravity (SMG) 
have been used to improve cartilaginous tissues, 
but the literature data are very diverse. 
Microgravity has been reported to reduce osteo-
genesis [5–8], and SMG has been shown to exert 
various effects on cartilaginous cells. Simulated mi-
crogravity has been reported by our group to reduce 
hypertrophy during chondrogenic differentiation of 
hMSCs [9]. However, SMG was also shown to de-
crease the chondrogenic potential of hMSCs [9–12]. 
Electromagnetic fields were shown to improve 
the chondrogenic potential of cells under certain 
conditions [13] and have been reported to devel-
op multiple effects on hMSCs [14]. Under Low fre-
quency electromagnetic fields (LF-EMF), the chon-
drogenic differentiation of hMSCs in 3D culture 
showed a  significant increase of collagen type II 
expression at higher cell passages, although no 
EMF effect was obtained under optimal differen-
tiation conditions [15]. However, EMF have also 
been reported to cause adverse effects [16–18], 
and the level of concern about EMF in the general 
population is high. Among general practitioners, 
there is no association between correct knowl-
edge and concern [19]. Nevertheless, there is 
a lack of studies examining general EMF effects on 
chondrogenic cells. We therefore examined in this 
study the influence of LF-EMF during chondrogen-
esis by a screen of the entire gene expression level 
to detect beneficial and adverse gene expression 
changes which might occur under EMF treatment 
of cartilage defects. To our knowledge there has 
been no similar approach in the literature. 
In a further step this study compared single and 
combined effects of LF-EMF and SMG on chondro-
genesis of hMSCs in scaffold-free high-density 3D 
pellet constructs. In contrast to previously used 
SMG bioreactor systems, a  controlled approach 
was used, which omitted any form of inadvertent 
EMF interference from power units of the SMG 
system by using solely an external motor gear. 
This approach made it possible to examine pure 
LF-EMF and pure SMG effects on chondrogenesis 
singly and combined for the first time.
The aim of this study was to show for the first 
time an entire gene expression screen, describe how 
LF-EMF and SMG affect chondrogenesis, and discuss 
whether they exert an influence on each other.
Material and methods
SMG
The LF-EMF/SMG bioreactor system consisted 
of an external motor gear and an internal vessel 
holder (Figure 1 A). Vessel rotation was transmit-
ted by a flexible shaft to a 10 ml RCCS vessel (Ro-
tary Cell Culture System; Synthecon Inc., Houston, 
USA) holder. The SMG bioreactor was combined 
with two magnetic Helmholtz coils (LF-EMF bio-
reactor) with an external cooling system and an 
external frequency generator. The vessel holder 
containing the pellet was situated within an in-
cubator (Figure 1 A). To assure SMG conditions 
for each pellet, the rotation speed was adjusted 
to the velocity at which the pellet was maintained 
in free-fall condition at approximately 7 rpm. Pre-
viously, resulting shear forces were determined 
using dummy pellets. Simulated microgravity was 
applied between days 15 and 21 within the ter-
minal chondrogenic differentiation phase, where 
hypertrophy is usually observed [20]. Pellets were 
transferred to the RCCS vessel during this phase. 
LF-EMF 
Two magnetic Helmholtz coils (D = 30 cm, 
278 turns of enamelled copper wire, D = 1.5 mm, 
R = 2.5 W, L = 38.5 mH for one coil, distance 
between coils 15 cm, current = 3 A) placed in 
a cooling box (Neue Magnetodyn GmbH, Munich, 
Germany) connected to an external water bath 
(refrigerated circulator, DC50-F3 Haake, Vreden, 
Germany) produced a  low frequency sinusoidal 
LF-EMF of 15 Hz and 5 mT magnetic flux densi-
ty. The coils were driven by a frequency generator 
with power amplifier (M80, Neue Magnetodyn) 
(Figures 1 A, B). The field was applied three times 
a day (every 435 min) for 45 min throughout the 
differentiation period of 21 days. All stimulations 
were performed inside an incubator (CB150, Bind-
er, Tuttlingen, Germany) under sterile conditions 
with a constant temperature level of 37 ±0.25°C. 
Chondrogenic differentiation of hMSCs
Adult bone marrow derived hMSCs (Lonza, 
Walkersville, MD) were expanded in monolayer 
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triple flasks (Nunc, Roskilde, Denmark) in a  hu-
midified atmosphere, 5% CO2, at 37°C, in growth 
medium (a-medium (Biochrom, Berlin, Germany) 
containing 10% fetal calf serum (PAA, Pasching, 
Austria), 50 U/ml penicillin/streptomycin (Bio-
chrom), 2  mM glutamine and 5 ng/ml recombi-
nant human fibroblast growth factor 2 (FGF-basic; 
Pepro Tech, Rocky Hill, NJ)). At 70–80% confluency, 
cells were passaged using 0.05% trypsin contain-
ing 0.02% EDTA (Biochrom). To generate pellet 
cultures, 4 × 105 hMSCs were centrifuged (150 g, 
5 min) at passage 4 in a 15 ml falcon tube (TPP, 
Switzerland). For differentiation, pellets were 
cultured over a  period of 21 days in differentia-
tion medium (high-glucose Dulbecco’s Modified 
Eagle’s Medium (DMEM; Biochrom) supplement-
ed with 10 mg/l insulin, 5.5 mg/l transferrin, 
5 µg/l selenium, 0.5 mg/ml bovine serum albumin, 
4.7 µg/ml linoleic acid, 0.1 µM dexamethasone, 
0.2 mM L-ascorbic acid-2-phosphate, 0.35 mM 
L-proline (all Sigma-Aldrich, Steinheim, Germa-
ny), 30 U/ml penicillin/streptomycin (Biochrom) 
and 10 ng/ml recombinant human transforming 
growth factor-β3 (TGF-β3; R&D Systems, Wies-
baden, Germany)). 
Pellet cultures were distributed into four 
groups: 1) controls cultured under 1g conditions 
(n = 14); 2) SMG (n = 4); 3) LF-EMF (n = 14); and 
4) LF-EMF/SMG (n = 5). The pellet culture system 
is limited to one culture per tube/RCCS. Pellet cul-
tures were also maintained in the absence of the 
growth factor TGF-β3.
Histology and immunohistochemistry
Pellets were embedded in Tissue-Tek (Sakura, 
Zoeterwoude, the Netherlands) prior to cryo-sec-
tioning. Serial sections were stained with safr-
anin-O  (Fluka, Buchs, Switzerland) and fast green 
(Chroma, Münster, Germany) as previously de-
scribed [21] to estimate the content and distribu-
tion of proteoglycans. For immunohistochemistry, 
samples were treated with chondroitinase and in-
cubated overnight at 4°C with a primary antibody 
for collagen type II (Department of Medical and 
Physiological Chemistry, Uppsala, Sweden) diluted 
1 : 6. For negative controls, the first antibody was 
omitted. Then samples were treated with a goat-de-
rived biotinylated mouse-specific antibody (Vector 
Laboratories, Burlingame, USA) 1 : 200 in TBS for 
1 h at room temperature (RT). Bound antibodies 
were stained with the VECTASTAIN ABC-Kit (Vector 
Laboratories, Burlingame, USA) and AEC (Sigma-Al-
drich, Steinheim, Germany). 
RNA preparation
Pellets from every group were separately dis-
rupted under frozen conditions at 300 rpm using 
a  Micro-Dismembrator S (Sartorius, Goettingen, 
Germany). RNA was directly isolated from freeze-
milled preparations using 1 ml of TRIzol (Invitro-
gen, Germany). After adding 0.2 ml of chloroform 
(Sigma-Aldrich, Steinheim, Germany) and vig-
orously shaking, samples were incubated at RT 
for 10 min. Then samples were centrifuged at 
15,000 × g for 20 min at 4°C, and the aqueous 
phase was transferred to a  fresh tube. RNA was 
directly isolated using RNeasy Mini Kit (Qiagen).
Microarray analysis
Isolated total RNA was checked for purity (Nano- 
Drop ND-1000, ThermoFisher, Waltham, USA) and 
integrity (Bioanalyzer 2100, Agilent, Santa Clara, 
USA). Control (WF) cultures were analyzed ver-
sus LF-EMF cultures (WF + EMF). 150 ng of total 
RNA was used for cDNA synthesis, amplification, 
fragmentation, and labelling using the Nugen Ap-
plause WTA ST and Encore Biotin labelling kits (Nu-
gen, San Antonio, USA). Labelled probes were hy-
Figure 1. SMG/LF-EMF bioreactor system: A – Schematic drawing of setup compounds: incubator (1), LF-EMF sole-
noid with external cooling system (2), external motor gear of the SMG (3) connected to RCCS vessel by a flexible 
shaft, floating pellet (white) within the RCCS vessel (4), external frequency generator of the LF-EMF (5). B – Drawing 
of the position of the SMG bioreactor and RCCS vessel within the Helmholtz coils
5 4 1 2
3
BA
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bridised to Affymetrix HuGene 2.0 ST GeneChips, 
washed, stained in an Affymetrix FS450 station, 
and scanned on an Affymetrix GeneChip Scanner 
3000 (Affymetrix, Santa Clara, USA). The array 
CEL-files were RMA normalised with the appropri-
ate program package from Affymetrix and analysed 
for differential expression in R using the packages 
limma and siggenes. The false discovery rate was 
set to 0.1 and no fold-change cutoff was applied. 
All arrays passed the quality control checks imple-
mented in the R package arrayQualityMetrics [22].
Quantitative real-time PCR analysis
For cDNA synthesis, 0.3 µg of total RNA was re-
verse-transcribed using QuantiTect Rev. Transcrip-
tion Kit (Qiagen, Hilden, Germany) with DNase 
treatment. Quantitative RT-PCR was performed 
with a LightCycler (Roche Applied Science, Mann-
heim, Germany) using 2 µl of SYBR Green Master 
Mix (Roche Applied Science, Mannheim, Germany) 
and 2.5 µl of 1 : 4 diluted cDNA in a 10 µl final vol-
ume. Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) forward TGC ACC ACC AAC TGC TTA GC, 
reverse GGC ATG GAC TGT GGT CAT GAG [23]; colla-
gen type II a1 chain (COL2A1) forward GTT ATC GAG 
TAC CGG TCA CAG AAG, reverse AGT ACT TGG GTC 
CTT TGG GTT TG [24]; collagen type 10 a1 chain 
(COLXA1) forward CAA GGC ACC ATC TCC AGG AA, 
reverse AAA GGG TAT TTG TGG CAG CAT ATT [25] 
and cartilage-specific proteoglycan core protein 
(aggrecan) forward CAG CAC CAG CAT CCC AGA, re-
verse CAG CAG TTG ATT CTG ATT CAC G [24] were 
used as primers. The following RT-PCR conditions 
were used for COL2A1 and aggrecan: polymerase 
activation 95°C for 10 min, 40 cycles at 95°C for 
10 s, 65°C for 10 s and 72°C for 15 s. Conditions 
for GAPDH and COLXA1: 95°C for 10 min, 40 cy-
cles at 95°C for 10 s, 60°C for 10 s and 72°C for 
15 s. Reactions were performed in triplicate. Rel-
ative quantification of the target gene expression 
was generated normalizing to GAPDH. The LF-EMF, 
SMG and LF-EMF/SMG values were normalized to 
controls cultured with TGF-β3 under 1g conditions. 
Statistical analysis
Analysis was conducted using Microsoft Excel 
2010 and Prism 5.02 software for Windows. Val-
ues were reported as the mean, standard devia-
tion and range. Statistical analysis was performed 
using the Mann-Whitney U-test as data were not 
normally distributed. The level of significance was 
set at p ≤ 0.05.
Results 
LF-EMF application
The magnetic flux density in the layer of the 
pellet cultures within the bioreactor has a homo-
geneous spatial distribution due to the Helmholtz 
configuration and is 5 mT ± 5%. The electric field at 
a certain distance from the coil centre was calcu-
lated with good approximation by Emax= 2 h π f Bx 
[25], where B
x
 is the peak value of the magnetic 
flux density, f its frequency and h is the height of 
the medium. With the given values the maximum 
induced electric field is below 1 mV/m in the re-
gion of the pellet. The current density was calcu-
lated by J = σ * E
max
, where σ is the conductance of 
the medium. With the given values and a conduc-
tance of 1.6 S/m for the medium [26] the current 
density is below 0.9 mA/m². 
The magnetic flux density of the Helmholtz-coils 
was simulated (Finite Element Method Magnetics 
(FEMM); Meeker, D. (2010), version 4.0.1) (Fig- 
ure 2 A). The simulation was validated by mea-
suring the B-field along the axis of the Helmholtz 
coils with a  Gaussmeter (Bell 640, F.W. Bell, Or-
lando, FL) (Figure 2 B). The earth’s static magnetic 
field perpendicular to the axis of the Helmholtz 
coils was measured at 45 mT.
SMG bioreactor 
Bioreactors simulating microgravity are used 
to avoid the enormous costs of space flight ex-
periments. The SMG condition often results in 
a  certain amount of shear stress. Within this 
study a  low resulting shear stress of 0.16 dyn/
cm2 ((Tmax= 3µ * Vpellet/2 rpellet) viscosity of the me-
dium (µ): 1.05 kg/ms; sedimentation rate (Vpellet): 
0.04 m/s; mean pellet radius (rpellet): 0.4 mm) was 
obtained. Values were obtained by measuring cav-
iar globes as dummy pellets (data not shown).
A conventional commercially available Rotatory 
Cell Culture System (RCCS) developed by NASA to 
simulate microgravity generates low EMF in the 
layer of the pellets in the range of 0.1–0.5 mT with 
a  sinusoidal modulation depending on the rota-
tion speed of the motor. The controlled bioreactor 
used in this study excluded low inadvertent EMF 
by using an external motor gear.
Histology and immunohistochemistry
At the end of the differentiation period, pos-
itive staining for safranin-O  and collagen type II 
was found in the centre of all pellet cultures 
treated with growth factors. Without growth fac-
tors, staining for safranin-O  and collagen type II 
was negative. Control pellet cultures treated with 
growth factors showed more uniform staining for 
safranin-O  and collagen type II. Cultures treated 
with LF-EMF alone revealed intense staining of 
safranin-O  in the middle of the pellet and simi-
lar localized staining for collagen type II. In pel-
lets cultured under single SMG there was weaker 
safranin-O  and collagen type II staining. Pellets 
exposed to SMG and LF-EMF showed strong safr-
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anin-O staining in the centre and uniform staining 
for collagen type II (Figure 3). 
Microarray analysis
Low-dose LF-EMF was applied to exert non- 
thermal cell stress on hMSCs during chondrogenic 
differentiation. Microarray analysis of hMSC cul-
tures exposed to LF-EMF was used to analyse the 
gene expression pattern and to provide a better 
understanding of LF-EMF mechanisms. At pas-
sage 5 under optimal conditions, the microarray 
analysis provided no significant changes in gene 
expression caused by LF-EMF treatment. Rigorous 
control of input RNA and microarray array data 
showed optimal quality. The microarray findings 
were consistent with the findings obtained by 
RT-PCR and our results obtained from former stud-
ies using optimal chondrogenic differentiation 
conditions [15]. The following link was created to 
allow review of records: GSE57298: http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?token=s-
rqhyuourzahzgp&acc=GSE57298.
Quantitative real-time PCR analysis
Chondrogenic differentiation was confirmed in 
cultures supplemented with TGF-β3 by RT-PCR for 
COL2A1 and aggrecan. All results were normalized 
to control cultures treated with TGF-β
3. Untreated 
pellet cultures without growth factors
 did not ex-
press any of the chondrogenic markers (data not 
shown) and were therefore not used as normaliz-
ing controls.
The SMG significantly reduced COLXA1 ex-
pression compared to control cultures treated 
with TGF-β
3 (Figure 4). The application of SMG 
also significantly decreased the expression of 
COL2A1 and aggrecan. Pure LF-EMF showed no 
significant effect on the expression of COL2A1, 
aggrecan and COLXA1 compared to the con-
trol as described by gene expression analysis. 
LF-EMF/SMG showed significantly higher COL2A1 
expression compared to SMG, but did not reach 
control levels. LF-EMF/SMG showed an insignif-
icant increase of COLXA1 expression compared 
to SMG. The COL2A1/COLXA1 ratio reached com-
parable values for control conditions and LF-EMF 
application, followed by LF-EMF/SMG and then 
SMG (Figure 4).
Discussion
A bioreactor system was applied, which makes 
it possible to examine the effect of LF-EMF and 
SMG on in vitro chondrogenesis of hMSCs in 3D 
Figure 2. Result of the simulation of the spatial distribution 
of the magnetic flux density within the Helmholtz coils in 
the position of the pellets (A). The simulation was validated 
by measuring the B-field along the axis of the Helmholtz 
coils with a Gaussmeter (B)
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culture separately or combined under controlled 
conditions. 
Single LF-EMF showed no effect on gene ex-
pression. Single SMG decreased the expression 
of COLXA1 and COL2A1. LF-EMF/SMG resulted in 
a significantly higher expression of COL2A1 when 
compared to SMG. LF-EMF/SMG insignificantly 
increased COLXA1 when compared to SMG. Alto-
gether, the combination therapy LF-EMF/SMG was 
not significantly superior to control culture levels 
treated with growth factors. However, LF-EMF/
SMG rescued the COL2A1 expression, which had 
been lowered by SMG. 
Regarding the literature, space flights alter 
bone metabolism, resulting in osteoporosis [27]. 
Osteoblasts have been shown to change expres-
Figure 3. Safranin-0 staining and immunohistochemistry for collagen type II of pellet cultures treated with no addi-
tional growth factor (–TGF); no additional growth factor in the presence of electromagnetic fields (–TGF +LF-EMF), 
TGF-β3 alone (+TGF); TGF-β3 in the presence of electromagnetic fields (+TGF +LF-EMF); TGF-β3 in combination with 
electromagnetic fields under simulated microgravity conditions (+LF-EMF +TGF +SMG) and TGF-β3 under simulated 
microgravity conditions (+LF-EMF +SMG)
Safranin 0 Collagen type II
100 µm
–TGF
–TGF
+EMF
+TGF
+TGF
+EMF
+TGF
+SMG
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sion levels under SMG [28]. Microarray experi-
ments showed lower osteogenic gene expression 
of hMSCs seeded onto gelatin microcarriers under 
SMG compared to static culture after 1 week [12]. 
In our controlled 3D in vitro study, 1 week of SMG 
was shown to be effective in reducing hypertro-
phy, which is a first step during terminal ossifica-
tion of hMSCs [9]. 
Studies investigating the effects of SMG on 
chondrogenesis do not provide consistent results. 
Results range from increased collagen type II ex-
pression in rabbit MSCs after 4 weeks of SMG in 
a  conventional direct motor gear RCCS [29] to 
reduced collagen type II expression of porcine 
chondrocytes when using a  random positioning 
machine [11]. Comparing SMG to real microgravity 
(RM), lower collagen type II expression in chondro-
cytes was observed under RM conditions [11, 30]. 
It therefore cannot be excluded that EMF effects 
reported in the literature were induced by direct 
power units, which might have influenced the SMG 
results. To obtain controlled study conditions, it is 
necessary to exclude inadvertent EMF effects by 
a direct motor gear in SMG studies. In this study, 
under controlled conditions, 1 week of SMG in-
duced a  significant reduction of COL2A1 expres-
sion.
Electromagnetic fields applications result in 
divergent data regarding cartilaginous cells [13, 
16]. Electromagnetic fields were shown to limit 
progression of OA in animal models [31–33]. It 
was reported that EMF counteracted IL-1β activity 
during chondrogenesis [34]. Electromagnetic fields 
have also been reported to stimulate growth fac-
tor synthesis of TGF-β1 [35]. In this study LF-EMF 
had no effect on chondrogenesis under optimal 
differentiation conditions, which has been report-
ed by our group previously [15]. Furthermore, we 
could show that LF-EMF application did not result 
in any gene expression changes of hMSCs during 
chondrogenic differentiation as examined by 
microarray analysis. This is of major importance 
as previous reports have linked EMF with an in-
creased risk of carcinogenesis [16–18] and there is 
a growing concern in public health regarding EMF 
[36]. In this study, three weeks of LF-EMF did not 
cause any inadvertent gene expression changes. 
However, we cannot exclude that gene expression 
 significant difference between groups p < 0.05; *significant difference compared to control p < 0.05.
Figure 4. Expression of mRNA for COL2A1, COLXA1, aggrecan and the COL2A1 to COLXA1 ratio in pellet cultures 
(hMSCs from passage five) treated with TGF-β3 and cultured under microgravity conditions (+SMG), under micro-
gravity conditions treated with LF-EMF (+SMG +LF-EMF) or stimulated with pure LF-EMF (+LF-EMF). All levels were 
normalized to control cultures treated with TGF-β3. Message levels of RNA preparations were analyzed by qRT-PCR 
and normalized to mRNA levels for GAPDH
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changes might occur during EMF treatment under 
modified conditions. 
The combined LF-EMF/SMG application result-
ed in a COL2A1/COLXA1 ratio that was not signifi-
cantly different from control cultures treated with 
TGF-β3. This implies that the combination therapy 
was not more effective than plain growth factor 
application. All parameters (time, shear stress, 
electromagnetic field) were chosen according to 
optimal results obtained for hypertrophy (SMG) 
and chondrogenesis (LF-EMF) regarding single ap-
plications [9, 15]. We therefore cannot recommend 
LF-EMF/SMG treatment in regenerative medicine 
for improvement of cartilaginous cells. Neverthe-
less, further studies are necessary to optimize the 
LF-EMF/SMG parameters and find a combination 
therapy which might render LF-EMF/SMG useful 
for tissue engineering.
However, LF-EMF/SMG treatment significantly 
increased the chondrogenic potential of hMSCs 
compared to SMG conditions. There was a rescue-
LF-EMF effect observed, which was dependent 
on the effects resulting from SMG treatment. We 
had demonstrated similar findings of LF-EMF ef-
fects under suboptimal cellular conditions where 
LF-EMF effects were only observed in hMSCs with 
a lowered differentiation potential [15]. As LF-EMF 
alone did not show any effect on chondrogenesis, 
the LF-EMF/SMG effect is probably linked to the al-
tered cellular situation induced by SMG. Increased 
growth factor synthesis [35] or anti-inflammatory 
effects of A2A and A3 adenosine receptors [37], as 
described for EMF, might be a reason for a re-im-
provement of the chondrogenic potential. EMF 
have also been proven to reduce the expression 
of pro-apoptotic and increase the expression of 
anti-apoptotic proteins [38]. Moreover, it has been 
reported that EMF are able to delay cellular se-
nescence mediated by heat shock proteins [39]. 
Recent data show that EMF might even be able 
to mediate cell reprogramming into a pluripotent 
state [40]. Therefore, there are various possible 
explanations for the influence of EMF on hMSCs 
during chondrogenic differentiation. Altogether, 
EMF seems to act on hMSCs regarding differenti-
ation in the form of a rescue effect, which is only 
observed under suboptimal cellular conditions.
In conclusion, LF-EMF did not cause any ad-
verse effects during chondrogenic differentiation. 
The applied combination therapy of LF-EMF/SMG 
was not significantly superior to control condi-
tions and therefore does not appear to be suitable 
for cartilage tissue engineering of hMSCs. Howev-
er, under LF-EMF/SMG there was a  rescue effect 
of LF-EMF observed regarding the chondrogenic 
potential of hMSCs. Further studies are necessary 
to improve LF-EMF/SMG combination therapies 
for hMSCs and evaluate the exact mechanism of 
LF-EMF rescue.
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